COVID-19 Courses & Training
The courses below will help you better understand COVID-19 guidelines and how to manage COVID-19 diagnostics and treatment.
ATTENTION! - To attend the classes below or track your completed courses, please login or register to the ASLM Academy.
E-Learning
Activity
SARS-CoV-2 ANTIGEN RAPID DIAGNOSTIC TEST TRAINING
View the latest training materials on ASLM's COVID-19 Ag RDT testing. You will learn about the COVID-19 pandemic, its mode of transmission and prevention measure, how to diagnose it using rapid diagnostic tests, how to improve testing outcomes, and you will gain knowledge and skills to utilize the test results to contribute epidemiological surveillance and control of the pandemic. This course was developed with funding from Unitaid and in partnership with the Clinton Health Access Initiative, Amref Health Africa, Last Mile Health and Africa Field Epidemiology Network under the stewardship of the Africa CDC.
ASLM’s COVID-19 ECHO Sessions
View the latest of ASLM’S COVID-19 ECHO SESSIONS
Session 1
Troubleshooting Common Challenges Associated with SARS-CoV-2 Diagnostic Test Establishment
Session 2
Latest Update On Available Technology to Detect COVID-19
Session 3
The Korean Experience for the African Continent
Session 4
Manufacturers of COVID-19 Molecular Diagnostic Tests: BD and Cepheid
Session 5
Manufacturers of COVID-19 Molecular Diagnostic Tests: QIAGEN & Thermo Fisher Scientific
Session 6
Serology Tests and Their Role in the Pandemic Response
Session 7
Implementing Fast Turn-Around Laboratory Testing for Control of COVID-19
Session 8
Manufacturers of Molecular Diagnostics Tests Pt3: Abbott and Bio-Rad
Session 9
Diagnostics in the COVID-19 Pandemic Response
Session 10
Best Practices Implementing a Structured Quality Assured Testing Program
Session 11
Procurement and Supply Chain for COVID-19 Diagnostics
Session 12
Facial Masks During COVID-19: Homemaking, Disinfection and Imaging
May 2020 Waste Management Training
COVID-19 Biosafety Guidance for Laboratories Confirmation
Session 13
Manufacturers of COVID-19 Molecular Diagnostics Tests: Abbott Serology in the Core Lab and Analytics
Session 14
Specimen Referral Systems for SARS-CoV-2 Testing
Session 15
Manufacturers of COVID-19 Molecular Diagnostics Tests: KH Medical Co., Ltd., South Korea & Inqaba Biotec
Session 16
Manufacturers of COVID-19 Molecular Diagnostics Tests: PerkinElmer & Pro-Med Diagnostics, South Africa
June 2020 LabCoP ECHO Session
Key Considerations for Differentiated Service Delivery in the Context of the Global COVID-19 Pandemic
Session 17
Manufacturers of COVID-19 Molecular Diagnostics Tests: EUROIMMUN AG, Germany and Hologic, USA
Session 18
Manufacturers of COVID-19 Molecular Diagnostics Tests: Roche Diagnostics International Ltd.
Session 19
Public Health Lab Networks and SARS-CoV-2 Testing: Challenges, Strategies, and Lessons from the USA
July 2020 LabCoP ECHO Session
No Time to Wait! Demand Creation for Early Infant Diagnosis of HIV
Session 20
Laboratory Data Management Considerations for COVID-19 Response
Session 21
Optimised Diagnostic Networks Key to Responding to COVID-19: Doing More with Less
August 2020 LabCoP ECHO Session
EQA Proficiency Testing Coverage, Results and Sustainability from the Perspective of a Service Provider
Special LabCoP ECHO Session
Establishing Diagnostic Connectivity for Laboratory Network Data Flow Across Conventional & POC Systems
Session 22
Self-Collection of Nasal Specimens: Lowering the Barrier to SARS-CoV-2 Testing and Access to Care
Session 23
COVID-19 Antigen Testing’s Role in the Helping Control the Pandemic
September 2020 LabCoP ECHO Session
Using Strategic Communications as a Tool for Social Change and Advocacy
Session 24
COVID-19 Testing Project – Independent Evaluation Results: What Do We Know About Performance?
Session 25
Considerations of Pooling Specimens for COVID-19 Testing by Real-Time RT-PCR
Session 26
Unpacking the Global Launch of COVID-19 Ag-RDT Testing
Session 27
Digital solutions supporting healthcare providers and stakeholders in their COVID-19 response
Session 28
Manufacturers of COVID-19 Rapid Diagnostics Tests: Abbott Panbio SARS-CoV-2 Antigen Rapid Test
Session 29
Manufacturers of COVID-19 Rapid Diagnostics Tests: STANDARD Q COVID-19 Antigen Rapid Test
Session 30
Funding & Procurement Mechanisms for SARS-CoV-2 Antigen Rapid Tests
October 2020 LabCoP ECHO session
Operationalising the M&E Sub-community of Practice: Improving M&E for HIV/TB and Emerging Challenges
Session 31
Manufacturers of COVID-19 Rapid Diagnostics Tests: LumiraDx SARS-CoV-2 Antigen Assay
Session 32
Launch of SARS-CoV-2 Antigen Rapid Test Training Package
1st LabCoP Extended Echo Session
Launch of the Score-TB Package
January 2021 LabCoP ECHO Session
PEPFAR Country Operational Plan (COP) 2021: laboratory systems strengthenin
Session 33
Testing Strategy for COVID-19 Antigen Rapid Diagnostic Tests
Session 34
Manufacturers of COVID-19 Rapid Diagnostics Tests: BD (USA) and DiaSorin (Italy)
Session 35
Expanding COVID-19 testing to reopen economies: A panel discussion
February 2021 LabCoP Extended ECHO Session
Roche & CDC Partnership: Developing Capacity and Improving Efficiencies in Laboratory Operations
Session 36
Genomic Surveillance of SARS-CoV-2 in South Africa: Implications on Transmission and Vaccine Efficacy
Session 37
African Experience on Expanding COVID-19 Testing Using SARS-CoV-2 Antigen Rapid Diagnostic Tests
Session 38
Impact of Novel Variants on COVID-19 Diagnostics
March 2021 LabCoP Extended ECHO Session
Leveraging Laboratory Information Management Systems in the COVID-19 Pandemic:
Session 39
Outcomes, Successes and Lessons from Implementing Emergency SARS-CoV-2 EQA Proficiency Testing in Africa
March 2021 LabCoP ECHO Session
New WHO Recommendations for Clinical and Service Delivery of HIV Prevention, Treatment and Care
Session 40
Manufacturers of COVID-19 Diagnostic Products: Thermo Fisher solutions for new SARS-CoV-2 variants
Session 41
Africa CDC Trusted Travel Platform: Creating a Trusted Network of Covid-19 Testing Laboratories
Session 42
Manufacturers of COVID-19 Diagnostic Products: Abbott Rapid Diagnostics and Beckman Coulter Inc.
Session 43
Tuberculosis and the COVID-19 Pandemic: Tackling the challenge
May 2021 LabCoP Extended ECHO Session
Global Fund COVID-19 Response Mechanism: SARS-CoV-2 Diagnostics Laboratory Systems Strengthening
Session 44
Country Experiences with the Use of Digital Tools for COVID-19
June 2021 LabCoP ECHO Session
GENERATIN GDEMAND FOR HIV VIRAL LOAD TESTING THROUGH TARGETED COMMUNICATIONS CAMPAIGNS
June 2021 LabCoP Extended ECHO Session
IMPLEMENTATION OF THE LATERAL-FLOW URINE LIPOARABINOMANNAN (LF-LAM) ASSAY
Session 45
Leveraging on Existing HIV Community Engagement to Respond to COVID-19 Challenges and Opportunities:
July 2021 LabCoP Extended ECHO Session
Innovating for Tuberculosis Diagnostics: MTB/XDR Assays and Considerations for Implementation
July 2021 LabCoP ECHO Session
Unlocking the Potential of Tiered Laboratory Networks Through Laboratory Mapping
Aug 2021 LabCoP ECHO Session
HIV VL Monitoring Among Patients on ART: Eight Sub-Saharan African Countries, 2013–2018
August 2021 LabCoP Extended ECHO Session
Human Papillomavirus (HPV) Testing Technologies: Hologic Aptima® HPV Assay
Session 46
Introducing COVIOS: a new, low-cost, high-quality COVID-19 antigen rapid diagnostic test
Session 47
Launch of COVID-19 Antigen Rapid Diagnostic Training e-Learning Platform
Session 48
The Evolving Role of Diagnostics in the COVID-19 Pandemic Response
Session 49
Manufacturers of COVID-19 Diagnostic Products: Siemens Healthineers & Thermo Fisher Scientific
Oct 2021 LabCoP Extended ECHO Session
Screening for Latent Tuberculosis Infection in Resource-limited Settings
Oct 2021 LabCoP Extended ECHO Session
German Epidemic Preparedness Team Laboratory Strengthening for External Quality Assessment. Experiences
Nov 2021 LabCoP Extended ECHO Session
Evaluating a Country Program: a Viral Load Example
Dec 2021 Special ECHO Session
The Diagnostic Evidence Hub: Its Role in Accelerating Uptake of Diagnostic Innovations
January 2022 LabCoP Extended ECHO Session
Experiences from Tanzania’s first Tuberculosis (TB) Diagnostic Network Assessment
February 2022 LabCoP ECHO Session
Introducing the HIV laboratory Waste Cost Assessment Framework (WCAF)
Session 50
Genomic Surveillance of SARS-CoV-2 in Africa: connecting the dots between Clinical and Sequencing Labs
March 2022 LabCoP ECHO Session
Generating Demand for HIV Viral Load Testing through Targeted Communications Campaigns
Session 51
External Quality Assessment for SARS-CoV-2 and Other Emerging Viruses
Session 52
Reviewing Efforts To Increase Community Access To Covid-19 Antigen Rapid Testing Services:
Session 53
UNVEILING THE GLOBAL FUND PROJECT STELLAR: STRENGTHENING COVID-19 DIAGNOSTIC AND LABORATORY SYSTEMS
April 2022 LabCoP Extended ECHO Session
Role of network Optimisation to achieve 95-90-0 for Mycobacterium TB Disease Elimination: Scaling up Test
April 2022 LabCoP ECHO Session
The Assay Verification Tool: Simplifying Verification and Validation in the Laboratory
April 2022 LabCoP Extended ECHO Session
ADDRESSING DIAGNOSTIC GAPS IN THE TB CARE CASCADE: MTB/XDR ASSAYS AND CONSIDERATIONS FOR IMPLEMENTATION
May 2022 LabCoP Extended ECHO Session
Manual for Selection of Molecular WHO-recommended RDTs for Detection of TB and Drug-resistant TB
June 2022 LabCoP Special ECHO Session
Diagnosis of Monkeypox: What are the Implications for Africa?
June 2022 LabCoP ECHO Session
Rollout and Implementation of SMS Results Relay and Electronic Result Reporting: The Zimbabwe Experience
June 2022 Extended ECHO Session
Non-Laboratory Worker Testing Cadres and Point-Of-Care Tests: an Essential Combination
July 2022 LabCoP Extended ECHO Session
Transforming Cervical Cancer Screening in Africa: The power of HPV DNA Testing
Mid-July 2022 LabCoP Extended ECHO Session
Digitally-Assisted Technical Assistance Support for Rapid Test Continuous Quality Improvement
August 2022 LabCoP ECHO Session
Measuring Progress of Integrated Sample Transport Systems for Clinical and Surveillance Purposes
September 2022 LabCoP ECHO Session
Optimising The Tb/Hiv Diagnostic Cascade Via The Clinic-Laboratory Interface Continuous Quality Program
November 2022 LabCoP ECHO Session
Local Manufacturing of Diagnostics in Africa - the case of MAScIR Diagnostic tests
December 2022 LabCoP ECHO Session
Integrated Hepatitis Testing as Part of The Response to WHO's Triple Elimination Strategy
January 2023 LabCoP ECHO Session
The Revised and New ISO 15189:2022 Standard That Specifies Requirements for Quality and Competence
February 2023 Waste Management Session
Rethinking Laboratory Waste Management in Members Countries: Where are We Now?
Feb 2023 LabCoP ECHO Session
The Revised and New ISO 15189:2022 Standard Part 2: Implications at the Country and Facility Level
Feb 2023 LabCoP Extended ECHO Session
Tool for Rapid Screening and accelerating Malaria Elimination in Low-Transmission Zones
Feb 2023 LabCoP Extended ECHO Session
Adopting The WHO-Recommended Three-Test Algorithm for Improving Quality of HIV Diagnosis
COVID-19 Diagnostics Training MOOC
Learn about the latest recommendations on COVID-19 diagnostics and testing from Future Learn